Intercede has reported 1H23 interims to September in line with the October trading update, showing 25% revenue growth (24% accounting for rounding) and EBITDA performance in line with expectations. With management’s approach to investing within existing means, we cautiously upgrade FY23 revenue (+£0.2m), but costs increase in line with revenue, leaving EBITDA unchanged. The very strong period represents Intercede’s second-best six months ever, delivered largely from existing customer orders and ....
22 Nov 2022
Intercede - Second half derisked
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Intercede - Second half derisked
Intercede Group plc (IGP:LON) | 110 0 0.0% | Mkt Cap: 63.8m
- Published:
22 Nov 2022 -
Author:
Andrew Darley | Kimberley Carstens -
Pages:
13
Intercede has reported 1H23 interims to September in line with the October trading update, showing 25% revenue growth (24% accounting for rounding) and EBITDA performance in line with expectations. With management’s approach to investing within existing means, we cautiously upgrade FY23 revenue (+£0.2m), but costs increase in line with revenue, leaving EBITDA unchanged. The very strong period represents Intercede’s second-best six months ever, delivered largely from existing customer orders and ....